mln9708
Showing 1 - 15 of 15
Advanced Cancers Trial in Houston (MLN9708, Vorinostat)
Completed
- Advanced Cancers
- MLN9708
- Vorinostat
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jul 8, 2022
Acute Leukemia, Chronic Leukemia, Myelodysplastic Syndrome Trial in Atlanta (MLN9708)
Completed
- Acute Leukemia
- +4 more
- MLN9708
-
Atlanta, GeorgiaNorthside Hospital
Sep 1, 2021
Acute Myeloid Leukemia Trial in Boston (MLN9708, Cytarabine, Daunorubicin)
Recruiting
- Acute Myeloid Leukemia
- MLN9708
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Jan 18, 2021
Allogeneic Hematopoietic Stem Cell Transplantation Trial in Milwaukee (MLN9708)
Completed
- Allogeneic Hematopoietic Stem Cell Transplantation
- MLN9708
-
Milwaukee, WisconsinFroedtert Hospital and the Medical College of Wisconsin
Nov 1, 2020
Multiple Myeloma Trial in Milwaukee (MLN9708, Dexamethasone, Bendamustine (multiple dose levels))
Completed
- Multiple Myeloma
- MLN9708
- +3 more
-
Milwaukee, WisconsinFroedtert Hospital and the Medical College of Wisconsin
Sep 30, 2020
Refractory Multiple Myeloma Trial in Germany (MLN9708, Pomalidomide 4 MG Oral Capsule, Dexamethasone)
Recruiting
- Refractory Multiple Myeloma
- MLN9708
- +3 more
-
Munich, Bayern, Germany
- +10 more
Sep 8, 2021
Newly Diagnosed Multiple Myeloma Trial in France (MLN9708, Lenalidomide, Dexamethasone)
Unknown status
- Newly Diagnosed Multiple Myeloma
- MLN9708
- +2 more
-
Bordeaux, France
- +9 more
Feb 18, 2020
Multiple Myeloma, Kahler Disease, Plasma-Cell Myeloma Trial in Cleveland (Panobinostat, Dexamethasone, MLN9708)
Relapsed or Refractory Acute Lymphoblastic Leukemia, Relapsed or Refractory Lymphoblastic Lymphoma, Mixed Phenotype Acute
Terminated
- Relapsed or Refractory Acute Lymphoblastic Leukemia
- +2 more
- MLN9708
- +3 more
-
Milwaukee, WisconsinFroedtert Hospital and the Medical College of Wisconsin
Dec 30, 2019
Breast Cancer Trial in Lebanon (Fulvestrant, MLN9708)
Terminated
- Breast Cancer
- Fulvestrant
- MLN9708
-
Lebanon, New HampshireDartmouth-Hitchcock Medical Center
Apr 25, 2019
Tumors, Lymphoma Trial in Lebanon (MLN9708, Nelfinavir)
Withdrawn
- Neoplasms
- Lymphoma
- MLN9708
- Nelfinavir
-
Lebanon, New HampshireDartmouth-Hitchcock Medical Center
Jan 30, 2018
Lymphoma, T-Cell Trial in Ann Arbor (MLN9708)
Completed
- Lymphoma, T-Cell
- MLN9708
-
Ann Arbor, MichiganUniversity of Michigan Hospital
Oct 10, 2017
Multiple Myeloma Trial in Spain (MLN9708, Lenalidomide, Dexamethasone)
Completed
- Multiple Myeloma
- MLN9708
- +2 more
-
A Coruña, Spain
- +73 more
Nov 28, 2017